House Bill 420, introduced in Maryland on March 10, 2025, aims to enhance emergency preparedness for anaphylaxis, particularly in youth camps. The bill establishes the Emergency and Allergy Treatment Program, which mandates that youth camps develop written policies for the administration of premeasured single doses of epinephrine during emergencies.

Key provisions of the bill include requirements for camp personnel to receive training on recognizing anaphylaxis symptoms and procedures for administering epinephrine. Camps must also have protocols for emergency follow-up and must notify parents or guardians about the camp's epinephrine policy prior to their child's attendance. Additionally, the bill allows registered nurse practitioners and physicians to prescribe epinephrine in the name of the camp, ensuring that the necessary medication is available on-site.

The introduction of House Bill 420 has sparked discussions among lawmakers and health advocates regarding the increasing prevalence of food allergies among children and the critical need for immediate response measures in emergency situations. Proponents argue that the bill will significantly improve safety for campers, while some opponents express concerns about the potential costs and logistical challenges of implementing the required training and policies.

The implications of this legislation are significant, as it addresses a growing public health concern and aims to reduce the risks associated with anaphylaxis in youth settings. If passed, the bill could set a precedent for similar measures in other states, potentially leading to broader changes in how emergency medical responses are handled in recreational environments.

As the legislative process continues, stakeholders are closely monitoring the bill's progress, anticipating further debates and potential amendments that could shape its final form. The outcome of House Bill 420 could have lasting effects on youth camp operations and the safety of children with severe allergies across Maryland.